Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Group Therapy for Primary Breast Cancer

ClinicalTrials.gov ID: NCT00220792

Public ClinicalTrials.gov record NCT00220792. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 9:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Trial of Group Therapy for Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether women with primary breast cancer who were randomly assigned to receive a brief group therapy would show a greater reduction in mood disturbance over time compared to those randomized to the control condition. We also hypothesized that women who were highly distressed at baseline would show the greatest benefit from participating in a support group, and that therapists with more training and experience would be most effective in reducing distress.

Study identification

NCT ID
NCT00220792
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Stanford University
Other
Enrollment
480 participants

Conditions and interventions

Conditions

Interventions

Behavioral

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1993 (Type not available)
Primary completion
Not listed
Completion
Jun 1998 (Type not available)
Last update posted
Aug 26, 2024

1993 – 1998

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Social Work Consultants, Inc Wichita Kansas 67202 —
Kalamazoo Community Clinical Oncology Program Kalamazoo Michigan 49007 —
Metro-Minnesota CCOP Saint Louis Park Minnesota 55416 —
Northern New Jersey CCOP Hackensack New Jersey 07601 —
North Shore University Hospital CCOP Manhasset New York 11030 —
University of Rochester CCOP Rochester New York 14642 —
Syracuse Hem/Onc CCOP Syracuse New York 13210 —
Northwest CCOP Tacoma Washington 98405 —
Marshfield Medical Research Foundation Marshfield Wisconsin 54449 —
Milwaukee CCOP Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00220792, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2024 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00220792 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →